glp-1 and gip hormones Emerging Role of Dual Receptor Agonists | DMSO The dual glucose-dependent insulinotropic polypeptide

Acknowledgments We are particularly grateful to Dr

In vivo experiments demonstrated that sitagliptin treatment reduced tumor growth and the expression of transforming growth factor- receptor I in xenografts (Lee et al., 2017)

[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Han J., Wu J., Silke J

In a nested case-control analysis performed with use of the French national health care insurance system (SNDS) database, Julien Bezin et al (2023), compared individuals with T2D, but not on GLP1-RA with those on GLP1-RA (10)

The inhibition of the onset and progression of DKD is an urgent issue, and the development of therapeutic approaches against DKD is required

10.1111/jnc.15521 [DOI] [PMC free article] [PubMed] [Google Scholar] 16.Xu J, Wei G, Wang J, Zhu J, Yu M, Zeng X, Wang H, Xie W, Kong H